Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
PLoS One ; 12(12): e0188950, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-29267304

RESUMEN

OBJECTIVE: To estimate the prevalence of World Health Organization-defined chronic suppurative otitis media (CSOM) and mild hearing impairment in a population representative sample of school-entry age children in rural Malawi. A secondary objective was to explore factors associated with CSOM in this population. METHODS: We performed a community-based cross-sectional study of children aged 4-6 years in Chikhwawa District, Southern Malawi, utilising a village-level cluster design. Participants underwent a structured clinical assessment, including video-otoscopy and screening audiometry. Diagnoses were made remotely by two otolaryngologists who independently reviewed clinical data and images collected in the field. Hearing impairment was classified as failure to hear a pure tone of 25dB or greater at 1, 2 or 4kHz. RESULTS: We recruited 281 children across 10 clusters. The prevalence estimates of CSOM, unilateral hearing impairment and bilateral hearing impairment were 5.4% (95%CI 2.2-8.6), 24.5% (95%CI 16.3-30.0), and 12.5% (95%CI 6.2-16.9) respectively. Middle ear disease was seen in 46.9% of children with hearing impairment. A trend towards increased risk of CSOM was observed with sleeping in a house with >2 other children. INTERPRETATION: We found a high burden of middle ear disease and preventable hearing impairment in our sample of school-entry age children in rural Malawi. There are important public health implications of these findings as CSOM and hearing impairment can affect educational outcomes, and may impact subsequent development. The identification and management of middle ear disease and hearing impairment represent major unmet needs in this population.


Asunto(s)
Pérdida Auditiva/epidemiología , Otitis Media Supurativa/epidemiología , Población Rural , Niño , Preescolar , Enfermedad Crónica , Análisis por Conglomerados , Estudios Transversales , Femenino , Pérdida Auditiva/etiología , Humanos , Malaui/epidemiología , Masculino , Otitis Media Supurativa/complicaciones , Otoscopía
2.
Lancet Infect Dis ; 16(9): 1052-1056, 2016 09.
Artículo en Inglés | MEDLINE | ID: mdl-27197552

RESUMEN

BACKGROUND: In survivors of Ebola virus disease, clinical sequelae including uveitis, arthralgia, and fatigue are common and necessitate systematic follow-up. However, the infection risk to health-care providers is poorly defined. Here we report Ebola virus RT-PCR data for body site and fluid samples from a large cohort of Ebola virus survivors at clinic follow-up. METHODS: In this cross-sectional cohort study, consecutive survivors of Ebola virus disease attending Kerry Town survivor clinic (Freetown, Sierra Leone), who had been discharged from the Kerry Town Ebola treatment unit, were invited to participate. We collected and tested axillary, blood, conjunctival, forehead, mouth, rectal, semen, urine, and vaginal specimens for presence of Ebola virus using RT-PCR. We regarded samples to be positive for Ebola virus disease if the cycle threshold was 40 or lower. We collected demographic data from survivors of their age, sex, time since discharge from the treatment unit, and length of acute admission in the Ebola treatment unit using anonymised standard forms. FINDINGS: Between April 2, and June 16, 2015, of 151 survivors of Ebola virus disease invited to participate, 112 (74%) provided consent. The median age of participants was 21·5 years (IQR 14-31·5) with 34 (30%) participants younger than 16 years. 50 (45%) of 112 participants were male. We tested a total of 555 specimens: 103 from the axilla, 93 from blood, 92 from conjunctiva, 54 from forehead, 105 from mouth, 17 from the rectum, one from semen, 69 from urine, and 21 from the vagina. The median time from Ebola treatment unit discharge to specimen collection was 142 days (IQR 127-159). 15 participants had a total of 74 swabs taken less than 100 days from discharge. The semen sample from one participant tested positive for Ebola virus at 114 days after discharge from the treatment unit; specimens taken from the axilla, blood, conjunctiva, forehead, mouth, rectum, and urine of the same participant tested negative. All specimens from the other 111 participants tested negative. INTERPRETATION: Patients recovering from Ebola virus disease who do not meet the case definition for acute disease pose a low infection risk to health-care providers 6 weeks after clearance of viraemia. Personal protective equipment after this time might be limited to standard barrier precautions, unless contact with fluids from sanctuary sites is envisaged. FUNDING: Save the Children International, Public Health England.


Asunto(s)
Ebolavirus/aislamiento & purificación , Fiebre Hemorrágica Ebola/complicaciones , Sobrevivientes , Viremia , Adulto , Artralgia/etiología , Biomarcadores/sangre , Biomarcadores/orina , Estudios de Cohortes , Estudios Transversales , Ebolavirus/patogenicidad , Femenino , Personal de Salud , Fiebre Hemorrágica Ebola/epidemiología , Fiebre Hemorrágica Ebola/virología , Humanos , Control de Infecciones/métodos , Masculino , Sierra Leona
3.
Trop Doct ; 46(3): 148-50, 2016 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-27106251

RESUMEN

The role of intravenous fluid and electrolyte replacement is increasingly recognised in the clinical management of Ebola virus disease. However, outbreaks typically occur in resource-limited settings where electrolyte measurement may be initially unavailable. Here we highlight potential strategies for empiric fluid and electrolyte therapy based on experience from Sierra Leone.


Asunto(s)
Electrólitos/uso terapéutico , Fluidoterapia/métodos , Fiebre Hemorrágica Ebola/terapia , Brotes de Enfermedades , Fiebre Hemorrágica Ebola/epidemiología , Humanos , Sierra Leona/epidemiología , Resultado del Tratamiento
5.
Lancet Infect Dis ; 15(11): 1292-9, 2015 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-26271406

RESUMEN

BACKGROUND: Clinical management of Ebola virus disease remains challenging. Routine laboratory analytics are often unavailable in the outbreak setting, and few data exist for the associated haematological and biochemical abnormalities. We aimed to assess laboratory and clinical data from patients with Ebola virus disease to better inform clinical management algorithms, improve understanding of key variables associated with outcome, and provide insight into the pathophysiology of Ebola virus disease. METHODS: We recruited all patients, alive on arrival, with confirmed Ebola virus disease who were admitted to the Kerry Town Ebola treatment centre in Sierra Leone. At admission, all patients had clinical presentation recorded and blood taken for Ebola confirmation using reverse-transcriptase-PCR (RT-PCR) and for haematological and biochemical analysis. We studied the association between these and clinical outcome. The primary outcome was discharge from the Ebola treatment centre. FINDINGS: 150 patients were admitted to the treatment centre between Dec 8, 2014, and Jan 9, 2015. The mean age of patients was 26 years (SD 14·7). Case fatality rate was 37% (55/150). Most patients presented with stage 2 (gastrointestinal involvement, 72/118 [61%]) and stage 3 (severe or complicated, 12/118 [10%]) disease. Acute kidney injury was common (52/104 [50%]), as were abnormal serum potassium (32/97 [33%]), severe hepatitis (54/92 [59%]), and raised C-reactive protein (21/100 [21%]). Haematological abnormalities were common, including raised haematocrit (15/100 [15%]), thrombocytopenia (47/104 [45%]), and granulocytosis (44/104 [42%]). Severe acute kidney injury, low RT-PCR cycle threshold (<20 cycles), and severe hepatitis were independently associated with mortality. INTERPRETATION: Ebola virus disease is associated with a high prevalence of haematological and biochemical abnormalities, even in mild disease and in the absence of gastrointestinal symptoms. Clinical care that targets hypovolaemia, electrolyte disturbance, and acute kidney injury is likely to reduce historically high case fatality rates. FUNDING: None.


Asunto(s)
Fiebre Hemorrágica Ebola/patología , Fiebre Hemorrágica Ebola/fisiopatología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Células Sanguíneas , Análisis Químico de la Sangre , Niño , Preescolar , Estudios de Cohortes , Femenino , Fiebre Hemorrágica Ebola/mortalidad , Humanos , Lactante , Recién Nacido , Masculino , Persona de Mediana Edad , Mortalidad , Sierra Leona , Resultado del Tratamiento , Adulto Joven
6.
Artículo en Inglés | MEDLINE | ID: mdl-19758576

RESUMEN

Survival of some polar fishes is associated with high levels of circulating antifreeze glycoproteins (AFGPs). AFGP prevent ice growth giving rise to thermal hysteresis. The inhibiting action of AFGPs implies that polar fish contain ice to which AFGPs adsorb. Cryopelagic Pagothenia borchgrevinki, inhabiting the ice-laden waters of McMurdo Sound, Antarctica, were assayed for ice and ice was found on skin, gills, in the intestine, and in the spleen. Two methods used to assess the number of ice crystals in spleens gave comparable results (12.1+/-1.9 and 22+/-3.8 per spleen). Attempts were made to measure the rate of uptake of ice by P. borchgrevinki held in cages immediately beneath the sub-ice platelet layer in McMurdo Sound; uptake was sporadic. Introduction of ice into fish by spray freezing a small patch of the integument resulted in detection of splenic ice after 1h, illustrating that a mechanism exists for ice transport from the periphery to the spleen. Splenic ice did not seem to be eliminated from fish held in ice-free water at -1.6 degrees C for approximately two months. The relatively small number of splenic ice crystals and the slow rate of ice uptake suggest efficient ice barriers exist in P. borchgrevinki.


Asunto(s)
Peces/metabolismo , Hielo , Bazo/metabolismo , Animales , Proteínas Anticongelantes/sangre
7.
J Phycol ; 44(5): 1164-70, 2008 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-27041713

RESUMEN

For marine algae, the benefits of drying out are often overshadowed by the stresses involved. Here we used laboratory and field experiments to examine both the costs and benefits of desiccation in the intertidal turf alga Endocladia muricata (Endlichter) J. Agardh. Laboratory experiments showed that when Endocladia is dry, photosynthesis stops, but thermotolerance increases to the point that the alga is protected from heat-induced mortality. Drying rates measured in a wind tunnel, combined with tidal data and measured wave splash, indicate that a substantial fraction of the year is spent "drying out" (∼30% of the total time available for photosynthesis). During these periods, the rate of drying determines how much time is spent hydrated and potentially engaged in photosynthesis, but also vulnerable to high temperatures. Turf algae such as Endocladia dry from the edge of a clump inward. Consequently, the clump center remains hydrated longer than the clump edge. The resulting regionalization of a clump results in notable patterns of frond mortality ("fairy rings," and zoned patterns of frond bleaching) within the Endocladia zone.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...